CORDIS
EU research results

CORDIS

English EN
Smart wearable and autonomous negative pressure device for wound monitoring and therapy

Smart wearable and autonomous negative pressure device for wound monitoring and therapy

Objective

SWAN-iCARE is an ambitious project aiming at developing an integrated autonomous device for the monitoring and the personalized management of chronic wounds, mainly diabetic foot ulcers and venous leg ulcers. Most foot and leg ulcers are caused by diabetes and vascular problems respectively but a remarkable number of them is also due to the co-mordibity influence of many other diseases (e.g. kidney disease, congestive heart failure, high blood pressure, inflammatory Bowel disease). More than 10 million in Europe suffer from chronic wounds, a number of which is expected to grow due to the aging of the population.
Core of the project is the fabrication of a conceptually new wearable negative pressure device equipped with Information and Communication Technologies. Such device will allow to:•\taccurately monitor many wound parameters via non-invasive integrated micro-sensors;•\tearly identify infections;•\tprovide remotely an innovative personalised two-line therapy via non-invasive micro-actuators to supplement the negative pressure wound therapy.
SWAN-iCARE novel idea focuses on the provision of pioneering two-line therapy at home: a first line based on a negative pressure device, a second line based on the integrated micro-actuators.
The physician's analysis of the collected data will be the basis for the decision and the remote control of the therapy. The closed-loop approach offered by SWAN-iCARE project provides unprecedented levels of care, improves patient's health condition and significantly lowers costs and need for hospitalisation, with obvious advantages for both patients and health care services.
The project follows an iterative validation approach which includes a series of test session in-vitro on human biological samples and in-vivo on humans.
A detailed impact analysis and business plan wil be conducted towards the successful commercialisation of the project results.
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

EXODUS ANONYMOS ETAIREIA PLIROFORIKIS

Address

Estias 1 & Mesogeion 73-75
11526 Athina

Greece

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

EU Contribution

€ 878 380

Administrative Contact

Leonidas Lymberopoulos (Dr.)

Participants (11)

Sort alphabetically

Sort by EU Contribution

Expand all

SWISSINNOV PRODUCT SARL

Switzerland

EU Contribution

€ 158 188

CSEM CENTRE SUISSE D'ELECTRONIQUE ET DE MICROTECHNIQUE SA - RECHERCHE ET DEVELOPPEMENT

Switzerland

EU Contribution

€ 1 533 734

HENRIK J NIELSEN

Denmark

CAP PARTNER APS, EWMA SECRETARIAT DFSG SECRETARIAT

Denmark

EU Contribution

€ 196 292

COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES

France

EU Contribution

€ 1 116 504

CENTRE HOSPITALIER UNIVERSITAIRE DE GRENOBLE

France

EU Contribution

€ 186 806

INSTITUTE OF COMMUNICATION AND COMPUTER SYSTEMS

Greece

EU Contribution

€ 325 787

HAEMOPHARM BIOFLUIDS SRL

Italy

EU Contribution

€ 262 340

UNIVERSITA DI PISA

Italy

EU Contribution

€ 1 139 740

EURORESEARCH SRL

Italy

EU Contribution

€ 135 712

SMITH & NEPHEW MEDICAL LIMITED

United Kingdom

EU Contribution

€ 180 516

Project information

Grant agreement ID: 317894

Status

Closed project

  • Start date

    1 September 2012

  • End date

    28 February 2017

Funded under:

FP7-ICT

  • Overall budget:

    € 8 043 982

  • EU contribution

    € 6 113 999

Coordinated by:

EXODUS ANONYMOS ETAIREIA PLIROFORIKIS

Greece